Song B, Tang Y-J, Zhang W-G, Wan C-C, Chen Y, Zhang L-J
Department of Hematology, Affiliated Taihe Hospital of Xi'an Jiaotong University Health Science Center, Shiyan, Hubei, China.
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9237. doi: 10.26355/eurrev_202009_22994.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1, by B. Song, Y.-J. Tang, W.-G. Zhang, C.-C. Wan, Y. Chen, L.-J. Zhang, published in Eur Rev Med Pharmacol Sci 2018; 22 (11): 3333-3341-DOI: 10.26355/eurrev_201806_15153-PMID: 29917183" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/15153.
由于本文涉嫌研究不当行为,且通讯作者未回应我们关于证明数据和图表原创性的要求,“B. Song、Y.-J. Tang、W.-G. Zhang、C.-C. Wan、Y. Chen、L.-J. Zhang发表于《欧洲医学与药理学评论》2018年;22(11):3333 - 3341 - DOI: 10.26355/eurrev_201806_15153 - PMID: 29917183的‘MiR - 143通过调节ERK1调控髓细胞白血病细胞HL - 60的增殖和凋亡’”已被撤回。出版方对由此可能造成的不便表示歉意。https://www.europeanreview.org/article/15153